Sign up Australia
Proactive Investors - Run By Investors For Investors

NetScientific boss proud of cancer diagnostic tool's achievements

NetScientific PLC (LON:NSCI) boss François Martelet talks Proactive through news its flagship company Vortex Biosciences has begun the commercial launch of its VTX1 Liquid Biopsy system.
It's the first time  Netscientific has been able to market a cancer diagnostic instrument and it has been executed on time and in line with market expectations, he says.
"It's a very fast and simple way to isolate and collect intact CTCs directly from the whole blood," he says.

 
Meet Great Boulder Resources Ltd, Mainstream Group Holdings Ltd, Blackstone Minerals Ltd, Pacific American Coal Ltd and Reward Minerals Ltd at our event, Sydney , 19 November 2018. Register here »
View full NSCI profile View Profile

Netscientific PLC Timeline

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use